Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole vs Tamoxifen with LHRH agonist in premenopausal breast cancer
jRCT2080220535Phase 3
- Sponsor
- AstraZeneca
- Start
- Mar 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Arimidex + Zoladex with Tamoxifen + Zoladex (2 arms).
02
Drugs
anastrozoletamoxifengoserelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT2080220535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220535.